Vesalius Biocapital offers venture capital
to young European innovative life science companies

logo
Portfolio News

ProFibrix

ProFibrix leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and regenerative medicine markets.
Exit through trade sale
 

http://www.profibrix.com

Therapeutics & Drug Delivery

The Netherlands

Sold